Amplify Weight Loss Drug & Treatment ETF (THNR)
| Assets | $4.08M |
| Expense Ratio | 0.59% |
| PE Ratio | 28.49 |
| Shares Out | 180,000 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 3,875 |
| Open | 22.99 |
| Previous Close | 22.87 |
| Day's Range | 22.99 - 23.16 |
| 52-Week Low | 22.57 |
| 52-Week High | 28.19 |
| Beta | n/a |
| Holdings | 31 |
| Inception Date | May 21, 2024 |
About THNR
Fund Home PageThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.
Top 10 Holdings
67.78% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.03% |
| Novo Nordisk A/S | NVO | 13.50% |
| Roche Holding AG | ROG | 5.52% |
| Pfizer Inc. | PFE | 5.16% |
| Amgen Inc. | AMGN | 5.08% |
| Merck & Co., Inc. | MRK | 5.02% |
| Chugai Pharmaceutical Co., Ltd. | 4519 | 4.98% |
| Thermo Fisher Scientific Inc. | TMO | 4.97% |
| AstraZeneca PLC | AZN | 4.84% |
| FUJIFILM Holdings Corporation | 4901 | 4.68% |
News
Disruptive Theme of the Week: Happy Post-Election Themes
With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to c...
Amplify ETFs Hits $10 Billion in Assets Amid New ETF Launches
As the ETF landscape continues to expand, more and more firms are crossing over significant AUM thresholds. That includes some now-veteran shops with strong, growing rosters, like Amplify ETFs.
SILJ, HACK, THNR: Trends in Thematic Investing
Amplify Junior Silver Miners ETF (SILJ) is up 28% year-to-date. Christian Magoon discusses the outlook for cybersecurity stocks, as Amplify's Cybersecurity ETF (HACK) is up 8% year-to-date.
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.